Breast Cancer Prevention Drug Linked to Bone Loss

This article originally appeared here.
Share this content:
Breast Cancer Prevention Drug Linked to Bone Loss
Breast Cancer Prevention Drug Linked to Bone Loss

TUESDAY, Feb. 7 (HealthDay News) -- Postmenopausal women receiving the aromatase inhibitor exemestane to prevent breast cancer are more likely to have bone loss, according to a study published online Feb. 7 in The Lancet Oncology.

Angela M. Cheung, M.D., from the University Health Network in Toronto, and colleagues analyzed bone mineral density (BMD) data from 351 postmenopausal women (median age, 61.3 years) who had been randomized to receive placebo or exemestane as part of a breast cancer prevention clinical trial.

After two years, the researchers found that, at the distal radius, total volumetric BMD and cortical thickness fell significantly more in women receiving exemestane compared with placebo (mean loss, 6.1 versus 1.8 percent and 7.9 versus 1.1 percent, respectively). Similar results were observed at the distal tibia (mean loss, 5.0 versus 1.3 percent and 7.6 versus 0.7 percent, respectively). Areal BMD also fell significantly more in the exemestane group at the lumbar spine, total hip, and femoral neck.

"Two years of treatment with exemestane worsens age-related bone loss in postmenopausal women despite calcium and vitamin D supplementation," Cheung and colleagues conclude. "To assess the effect of our findings on fracture risk, long-term follow-up is needed."

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs